TGTX Sale Disclosure
Charney Laurence N · SEC Form 4 · Filed Sep 14, 2026
Sale
Calculated transaction value
$274.8K
Charney Laurence N Director
TGTX
TG Therapeutics
TGTX
Transaction date
Sep 10, 2026
Public filing date
Sep 14, 2026
Filing lag
Filed 4 days later
TGTX daily price context
Close on/before transaction
$55.39
Sep 10, 2026
Close before public filing
$53.89
Sep 11, 2026
Return since public filing
+3.64%
Through Sep 16, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 5,000 shares @ $54.96
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001437749-26-030343
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$274.8K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Tg Therapeutics, Inc. TGTX Current | Sale | Sep 10, 2026 | $274.8K |